Home > Insider Trading > Filing (0001181431-10-031765)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1487371	Genmark Diagnostics Inc.	GNMK	Surgical & Medical Instruments & Apparatus (3841)	272053069

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366268	Faiz Jon Kayyem	757 S. Raymond Avenue Pasadena CA 91105	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-03	61,651	$0.00	61,651	No	4	J	Indirect	HI Charitable Remainder Uni Trust
Common Stock	Acquisiton	2010-06-03	124,934	$0.00	124,934	No	4	J	Indirect	Jon Faiz Kayyem and Paige N. Gates Family Trust
Common Stock	Acquisiton	2010-06-03	319,308	$0.00	319,308	No	4	J	Indirect	IFIN LP
Common Stock	Acquisiton	2010-06-03	250,000	$6.00	569,308	No	4	P	Indirect	IFIN LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	HI Charitable Remainder Uni Trust
No	4	J	Indirect	Jon Faiz Kayyem and Paige N. Gates Family Trust
No	4	J	Indirect	IFIN LP
No	4	P	Indirect	IFIN LP

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2010-06-03	248,568	$0.00	248,568	$6.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
248,568		2019-12-23	No	4	J	Direct

Footnotes

Received in exchange for ordinary shares of Osmetech plc in connection with the reorganization of GenMark Diagnostics, Inc. The reorganization resulted in GenMark becoming the parent company of Osmetech, GenMark's parent company prior to the reorganization, through a scheme of arrangement under Part 26 of the U.K. Companies Act of 2006, but did not alter the proportionate interests of security holders. The number of shares issuable pursuant to the reorganization was determined pursuant to an exchange ratio of 230 ordinary shares of Osmetech for one share of GenMark common stock.
Mr. Kayyem is the trustee of the HI Charitable Remainder Uni Trust, trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000, and the President of In-Motion LLC, the general partner of IFIN LP. Mr Kayyem disclains beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
Received in exchange for options to purchase ordinary shares of Osmetech plc. The number of options issuable pursuant to the reorganization was determined pursuant to an exchange ratio of 230 options to purchase ordinary shares of Osmetech for an option to purchase one share of GenMark common stock.
25% of the option shares vest and become exercisable on December 23, 2010 and the remaining option shares vest and become exercisable in 36 monthly installments thereafter.